Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Tirdad T. Zangeneh; William D. Lainhart; Nathan P. Wiederhold; Mohanad M. Al-Obaidi

doi:10.1093/mmy/myad104

Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Tirdad T. Zangeneh
, William D. Lainhart
, Nathan P. Wiederhold
, Mohanad M. Al-Obaidi

Producción científica: Article › revisión exhaustiva

1 Cita (Scopus)

Resumen

The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

Idioma original	English (US)
Número de artículo	myad104
Publicación	Medical Mycology
Volumen	61
N.º	10
DOI	https://doi.org/10.1093/mmy/myad104
Estado	Published - oct 1 2023

ASJC Scopus subject areas

Infectious Diseases

Acceder al documento

10.1093/mmy/myad104

Otros archivos y enlaces

Link to publication in Scopus

Citar esto

@article{5d69173ce1d64ba8947ee4bb7d15a379,

title = "Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region",

abstract = "The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.",

keywords = "antifungal susceptibility, antifungal therapy, coccidioidomycosis",

author = "Zangeneh, \{Tirdad T.\} and Lainhart, \{William D.\} and Wiederhold, \{Nathan P.\} and Al-Obaidi, \{Mohanad M.\}",

note = "Publisher Copyright: {\textcopyright} 2023 The Author(s). Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.",

year = "2023",

month = oct,

day = "1",

doi = "10.1093/mmy/myad104",

language = "English (US)",

volume = "61",

journal = "Medical Mycology",

issn = "1369-3786",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Coccidioides species antifungal susceptibility testing

T2 - Experience from a large healthcare system in the endemic region

AU - Zangeneh, Tirdad T.

AU - Lainhart, William D.

AU - Wiederhold, Nathan P.

AU - Al-Obaidi, Mohanad M.

PY - 2023/10/1

Y1 - 2023/10/1

N2 - The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

AB - The clinical utility of Coccidioides species antifungal susceptibility testing (AST) remains unclear. This study describes the clinical course of eight patients with severe or chronic coccidioidomycosis and subsequent Coccidioides AST. We present the clinical manifestations, antifungal treatment regimens, and clinical outcomes for these patients.

KW - antifungal susceptibility

KW - antifungal therapy

KW - coccidioidomycosis

UR - https://www.scopus.com/pages/publications/85174752289

UR - https://www.scopus.com/pages/publications/85174752289#tab=citedBy

U2 - 10.1093/mmy/myad104

DO - 10.1093/mmy/myad104

M3 - Article

C2 - 37804176

AN - SCOPUS:85174752289

SN - 1369-3786

VL - 61

JO - Medical Mycology

JF - Medical Mycology

IS - 10

M1 - myad104

ER -

Coccidioides species antifungal susceptibility testing: Experience from a large healthcare system in the endemic region

Resumen

ASJC Scopus subject areas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto